Stocks TelegraphStocks Telegraph
Stock Ideas

IGMS Financial Statements and Analysis

NASDAQ : IGMS

IGM Biosciences, Inc.

$1.61
0.035+2.23%
Open: 1:00 PM
60.39
BESG ScoreESG Rating

IGMS FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

IGMS Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue516.00K1.254M497.00K651.00K509.00K
cost of revenue02.276M2.176M2.181M2.259M
gross profit516.00K-1.022M-1.679M-1.53M-1.75M
gross profit ratio1.00-0.815-3.378-2.35-3.438
research and development expenses46.142M39.686M43.815M52.009M54.762M
general and administrative expenses18.761M10.649M10.538M11.58M12.507M
selling and marketing expenses00000
selling general and administrative expenses18.761M10.649M10.538M11.58M12.507M
other expenses0-41.962M000
operating expenses64.903M50.335M54.353M63.589M67.269M
cost and expenses64.903M52.611M54.353M65.77M67.269M
interest income2.957M3.455M4.04M4.666M5.011M
interest expense00000
depreciation and amortization2.307M2.276M2.176M2.181M2.259M
ebitda-62.08M-49.081M-51.68M-62.938M-66.76M
ebitda ratio-120.31-39.14-108.362-96.679-131.159
operating income-64.387M-51.357M-53.856M-65.119M-66.76M
operating income ratio-124.781-40.955-108.362-100.029-131.159
total other income expenses net2.957M3.455M4.04M4.666M5.011M
income before tax-61.43M-47.902M-49.816M-60.453M-61.749M
income before tax ratio-119.05-38.199-100.233-92.862-121.314
income tax expense00-2.176M242.00K-240.00K
net income-61.43M-47.902M-49.816M-60.695M-61.989M
net income ratio-119.05-38.199-100.233-93.233-121.786
eps-1.01-0.79-0.83-1.01-1.04
eps diluted-1.01-0.79-0.83-1.01-1.04
weighted average shs out60.658M60.434M60.114M59.829M59.58M
weighted average shs out dil60.658M60.434M60.114M59.829M59.58M
Graph

IGMS Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents42.875M67.263M79.498M113.112M174.794M
short term investments175.912M189.407M214.595M225.157M212.197M
cash and short term investments218.787M256.67M294.093M338.269M386.991M
net receivables00900.00K800.00K0
inventory00000
other current assets10.844M18.085M8.985M8.528M10.787M
total current assets229.631M266.018M302.753M347.597M398.395M
property plant equipment net73.738M69.052M71.774M74.005M73.972M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets1.139M1.431M1.605M1.809M1.983M
total non current assets74.877M70.483M73.379M75.814M75.955M
other assets01.00000
total assets304.508M336.501M376.132M423.411M474.35M
account payables3.545M3.259M3.995M1.326M3.913M
short term debt6.695M11.874M6.628M5.834M6.206M
tax payables00000
deferred revenue2.653M1.998M3.655M3.777M4.913M
other current liabilities31.071M20.524M23.652M31.544M27.933M
total current liabilities43.964M37.655M37.93M42.481M42.965M
long term debt39.162M33.436M34.30M34.672M34.984M
deferred revenue non current0143.052M142.649M143.024M142.539M
deferred tax liabilities non current0-143.052M000
other non current liabilities142.435M0000
total non current liabilities181.597M176.488M176.949M177.696M177.523M
other liabilities001.0000
capital lease obligations45.857M33.436M34.30M34.672M41.19M
total liabilities225.561M214.143M214.879M220.177M220.488M
preferred stock00000
common stock340.00K592.00K589.00K586.00K584.00K
retained earnings-980.39M-918.96M-871.058M-821.242M-760.547M
accumulated other comprehensive income loss421.00K-195.00K-128.00K151.00K-277.00K
other total stockholders equity1.059B1.041B1.032B1.024B1.014B
total stockholders equity78.947M122.358M161.253M203.234M253.862M
total equity78.947M122.358M161.253M203.234M253.862M
total liabilities and stockholders equity304.508M336.501M376.132M423.411M474.35M
minority interest00000
total investments175.912M189.407M214.595M225.157M212.197M
total debt45.857M39.373M40.928M40.506M41.19M
net debt2.982M-27.89M-38.57M-72.606M-133.604M
Graph

IGMS Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax000-16.117M-2.352M
stock based compensation16.202M8.428M7.922M9.237M11.954M
change in working capital3.88M-896.00K-2.984M-643.00K4.743M
accounts receivables00000
inventory00000
accounts payables203.00K-802.00K2.648M-2.518M526.00K
other working capital5.726M-94.00K-5.632M1.875M4.217M
other non cash items656.00K14.502M9.911M18.029M5.264M
net cash provided by operating activities-38.385M-37.374M-42.417M-48.008M-40.121M
investments in property plant and equipment-1.292M-1.214M-2.484M-1.448M-3.083M
acquisitions net-32.00K32.00K000
purchases of investments-62.542M-62.238M-54.789M-89.564M-109.784M
sales maturities of investments80.30M87.944M65.924M76.319M132.416M
other investing activites-3.448M25.738M-1.132M00
net cash used for investing activites12.986M24.524M8.651M-14.693M19.549M
debt repayment00000
common stock issued-839.00K648.00K191.00K402.00K44.617M
common stock repurchased1.00K-1.00K000
dividends paid00000
other financing activites2.039M-33.00K-39.00K022.00K
net cash used provided by financing activities1.201M615.00K152.00K402.00K44.639M
effect of forex changes on cash00000
net change in cash-24.198M-12.235M-33.614M-62.299M24.067M
cash at end of period43.065M67.263M79.498M113.112M175.411M
cash at beginning of period67.263M79.498M113.112M175.411M151.344M
operating cashflow-38.385M-37.374M-42.417M-48.008M-40.121M
capital expenditure-1.292M-1.214M-2.484M-1.448M-3.083M
free cash flow-39.677M-38.588M-44.901M-49.456M-43.204M
Graph

Frequently Asked Questions

How did IGM Biosciences, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, IGMS generated $516.00K in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did IGM Biosciences, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. IGM Biosciences, Inc. reported a $516.00K Gross Profit for the quarter ended Sep 30, 2024.

Have IGMS's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. IGMS incurred $64.90M worth of Operating Expenses, while it generated -$64.39M worth of Operating Income.

How much Net Income has IGMS posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from IGM Biosciences, Inc., the company generated -$61.43M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did IGM Biosciences, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to IGM Biosciences, Inc. as of the end of the last quarter was $42.88M.

What are IGMS's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, IGMS had Total Net Receivables of $0.00.

In terms of Total Assets and Current Assets, where did IGM Biosciences, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of IGMS were $229.63M, while the Total Assets stand at $304.51M.

As of the last quarter, how much Total Debt did IGM Biosciences, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of IGMS's debt was $45.86M at the end of the last quarter.

What were IGMS's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, IGMS reported total liabilities of $225.56M.

How much did IGMS's Working Capital change over the last quarter?

Working Capital Change for IGMS was $3.88M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

IGMS generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. IGMS generated -$38.39M of Cash from Operating Activities during its recently reported quarter.

What was IGMS's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. IGMS reported a -$24.20M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph